Health

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial – DocWire News

Intensive Care Med. 2021 Nov 10. doi: 10.1007/s00134-021-06573-1. Online ahead of print.ABSTRACTPURPOSE: We compared dexamethasone…

Published

4 years ago

November 10, 2021

Noosa Online News Publisher

Intensive Care Med. 2021 Nov 10. doi: 10.1007/s00134-021-06573-1. Online ahead of print.
ABSTRACT
PURPOSE: We compared dexamethasone 12 versus 6 mg daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the…

Click here to view the original article.

Related Topics:Australia Docwirenews.com

Up Next

Geelong Covid cases: Covenant College closes; 11 new infections – Geelong Advertiser

Don't Miss

Immunologist Dr. Anthony Leonardi speaks on Long COVID and the dangers posed by SARS-CoV-2 – WSWS

General14 hours ago

Queensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965

Noosa News16 hours ago

Inquest into Rosemarie Campbell’s death three days after gastric bypass surgery hears of ‘massive loss’ to family

Noosa News8 hours ago

Reubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast

General23 hours ago

Indonesia airdropped aid for Palestinians in Gaza, but experts question its effectiveness

Noosa Online News

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial – DocWire News

Trending